Article
Angiogenically stimulated alternative monocytes maintain their pro-angiogenic and non-inflammatory phenotype in long-term co-cultures with HUVEC.
Clinical hemorheology and microcirculation - 1 Jan 2014
Krüger Anne, Mayer Anke, Roch Toralf, Schulz Christian, Lendlein Andreas, Jung Friedrich
Abstract excerpt
Angiogenically stimulated alternative monocytes (aMO2) could be established as cellular release system accelerating the endothelialization of polymers rendering their surfaces hemocompatibility in a short-term study. However, for their clinical application it is essential that aMO2 do not switch back to the MO1 state sustaining their capability as cellular release system over an extended period of time. We...
Topics
- Angiogenesis Inducing Agents
- Biocompatible Materials
- Cells, Cultured
- Coculture Techniques
- Cytokines
- Epoprostenol
- Human Umbilical Vein Endothelial Cells
- Humans
- Inflammation
- Monocytes
- Neovascularization, Pathologic
- Neovascularization, Physiologic
